DOI: https://dx.doi.org/10.18203/2349-2902.isj20222236
Published: 2022-08-26

A study of total mesorectal excision for rectal cancer-upfront and after neoadjuvant chemotherapy or chemoradiation

Sajan Bijyal, Avinash Rajra, Virta Chauhan

Abstract


Background: Colorectal cancer is a major cause of morbidity and mortality throughout the world. The incidence of rectal carcinoma is increasing in developing countries. Challenge in preoperative evaluation remains to identify patients who might benefit from neoadjuvant chemotherapy or chemoradiation (NACT/RT). The aim of this study was to study the correlation of final histopathology specimen (pathological tumor regression grade) with preoperative MRI (magnetic resonance tumor regression grade) (mrTRG).

Method: This was a prospective observational analysis with operable rectal cancer of mid or distal rectum who underwent total mesorectal excision either upfront or following CT/RT. Preoperative MRI was done for local staging and also to assess response to neo-adjuvant CT/RT. Histo-pathological specimen was assessed for pathological tumor regression and correlation between mrTRG and pathological tumor regression grading (pTRG) analysed.

Results: Out of 79 patients, 69 patients received NACRT and 10 patients underwent upfront surgery. On bivariate analysis mrTRG and pTRG corresponded in 47 patients whereas in 22 patients it didn’t correspond. There was a statistically significant agreement between mrTRG and pTRG (p=0.0491).

Conclusions: mrTRG grading was identified as a reliable predictor of pathological response after neoadjuvant chemoradiotherapy and thus a predictor of completeness of resection. So, efforts should be routinely done to do a mrTRG grading as it not only provides oncological safety but also reduces post operative mortality.     


Keywords


Carcinoma, Neoadjuvant chemoradiotherapy, Adenocarcinoma, mrTRG, pTRG

Full Text:

PDF

References


Boyle P. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321(7264):805-8.

World Cancer Research Fund and American Institute for Cancer Research Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research. 2007.

Ries L AG, Melbert D, Krapcho M. SEER cancer statistics review, 2000;1975-2005.

Mohandas K. Colorectal cancer in India: controversies, enigmas and primary prevention. Indian J Gastroenterol. 2011;30(1):3-6.

Langner C, Schneider N. Prognostic stratification of colorectal cancer patients: current perspectives. Cancer Management Res. 2014:291.

The National Comprehensive Cancer Network (NCCN) has announced updates to the NCCN Clinical Practice Guidelines in Oncology. Pharmaco Economics Outcomes News. 2008;NA;(552):3.

Couch D. Complete radiotherapy response in rectal cancer: A review of the evidence. World J Gastroenterol. 2016;22(2):467.

Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys. 2001;51:371-83.

MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243(1):132-9.

MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333(7572):779.

Beets-Tan RG, Beets GL, Vliegen RF. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357(9255):497-504.

Herzog T, Belyaev O, Chromik AM. TME quality in rectal cancer surgery. Eur J Med Res. 2010;15(7):292-6.

Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M et al. Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol. 1986;150(3):195-203.

Langley R, Fidler I. The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011;128(11):2527-35.

Yeo S, Kim D, Kim T, Chang H, Oh J, Park W et al. Pathologic Complete Response of Primary Tumor following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer. Ann Surg. 2010;252(6):998-1004.

Fang CB, Caroline MC, Fernanda BF, Fonseca VA, Carvalho MP, Klug WA. Is the delayed surgery after neoadjuvant chemoradiation beneficial for locally advanced rectal cancer. ABCD. 2013;26:1.

Sclafani F, Brown G, Cunningham D, Wotherspoon A, Mendes L, Balyasnikova S et al. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Bri J Cancer. 2017;117(10):1478-85.

Rengo M, Picchia S, Marzi S, Bellini D, Caruso D, Caterino M et al. Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. Oncotarget. 2017;8(70).

Chen C, Lee R, Lin J, Wang L, Yang S. How Accurate is Magnetic Resonance Imaging in Restaging Rectal Cancer in Patients Receiving Preoperative Combined Chemoradiotherapy? Diseases of the Colon Rectum. 2005;48(4):722-8.